Genetic Technologies
Genetic Technologies Gets Nasdaq Delisting Warning
The Australian genomic testing company said that its American Depositary Shares have failed to meet the Nasdaq's minimum bid price requirement for continued listing.
In Brief This Week: OpGen, MDxHealth, Dante Genomics, More
New items for the week of Oct. 24, 2022.
In Brief This Week: Centogene, Novacyt, T2 Biosystems, Inotiv, Oxford Nanopore, More
News items for the week of July 11, 2022.
Genetic Technologies Lab Gets Regulatory Approvals in US, Australia
The lab has received NATA accreditation and CLIA certification, enabling the launch of the company's multi-disease risk assessment test in Australia and the US.
In Brief This Week: Pathogenomix, Uniogen, Genetic Technologies, DnaNudge, Gravity Diagnostics, More
News items for the week of Jan. 17, 2022.
May 26, 2020
Genetic Technologies Prices $8M Public Offering
Apr 20, 2020
Genetic Technologies Prices $1.4M Direct Offering
Apr 1, 2020